DISCOUNT ZERTIFIKAT - ELI LILLY & CO Stock

Certificat

DE000PC0N060

Market Closed - Deutsche Boerse AG 15:40:14 2024-07-03 EDT
360.8 EUR -0.48% Intraday chart for DISCOUNT ZERTIFIKAT - ELI LILLY & CO
Current month-0.78%
1 month+1.41%
Date Price Change
24-07-03 360.8 -0.48%
24-07-02 362.5 -0.17%
24-07-01 363.1 -0.13%
24-06-28 363.6 0.00%
24-06-27 363.6 -0.26%

Delayed Quote Deutsche Boerse AG

Last update July 03, 2024 at 03:40 pm

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying ELI LILLY AND COMPANY
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC0N06
ISINDE000PC0N060
Date issued 2023-04-03
Cap 400 $
Last trading day 2024-12-20
Maturity 2024-12-20 (170 Days)
Parity 1 : 1
Emission price 274.1
Emission volume N/A
Payment day 2024-12-30
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 0.000000 %
Sideways yield 0.000000 %
Sideways yield pa 0.000000 %
Outperformance point- $
Break even 0.000000 €
Highest since issue 364.6
Lowest since issue 279.7
Distance Cap 498.1 $
Distance Cap %+55.46%
Max. earning-
Max. earning % 0.000000 %

Company Profile

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
More about the company

Ratings for Eli Lilly and Company

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Eli Lilly and Company

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
898.1 USD
Average target price
870.3 USD
Spread / Average Target
-3.10%
Consensus